Third U.S. Patent Approved for Protexis's System of E-Commerce and Copy Protection for Digital Content and Software
October 20, 2004, Vancouver, BC – Protexis, provider of state-of-the-art on-demand e-commerce services for software publishers, today announced that the U.S. Patent and Trademark Office has approved a patent that expands the company's patent holdings surrounding its system of copy protection, electronic licensing, and e-commerce services for software and digital content. Two other patents covering fundamental aspects of the Protexis platform have already been issued, with several others pending.
"These patents cover proprietary technology that enables Protexis to offer software publishers very powerful new ways to market their software, including try-before-you-buy, and other opportunities to sample and share new software features that ultimately can increase revenue for publishers at very low cost," said Karl Hirsch, CEO of Protexis.
"Receiving this patent is another important milestone as Protexis accelerates on its growth plan. We're committed to building an intellectual property portfolio around our expertise in enabling state-of-the-art e-commerce and digital rights management (DRM) for software publishers," said Hirsch. "We have additional patents pending and will continue to build legal protection for our innovations that help our customers compete successfully."
About Protexis
Protexis empowers software publishers with a state-of-the-art e-commerce platform that helps to build their online business, by reducing costs, increasing revenue opportunities and profitability, and building closer customer relationships. Its customers are leading software publishers, including CNET Networks, DivX Networks and Sage Technologies, and many others. Protexis technology enables the secure digital sale of millions of copies of software worldwide. Protexis is headquartered in Vancouver, British Columbia, with offices in Seattle, Washington. The company is privately-held, and its investors include CNET Networks [NASDAQ: CNET], Canadian Science and Technology Growth Fund, Inc. and Trudell Medical. For more information, please visit www.protexis.com.
For additional information on Protexis and its electronic software licensing products call 604.915.5200 or e-mail info@protexis.com.
Press Contact:
NeoTerra Group
Jessie Brumfiel
805.686.8407
jbrumfiel@neoterragroup.com
Note: This News Release may contain future-oriented information that is based upon the Protexis business plans.
